Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yunpeng Ren
Institutions:
Shanghai Medical College of Fudan University,
Fudan University
Observed institutions:
Shanghai Medical College of Fudan University,
Harbin Institute of Technology,
Fudan University
ORCID:
0000-0001-8500-2096
Observed ORCID:
0000-0001-8500-2096
OpenAlex ID:
A5045616086
PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C
2023
·
Nan Xu
, Yunpeng Ren
, et al.
·
Cell Reports
·
54
RBM10 Loss Promotes EGFR -Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2023
·
Yufang Bao
, Sirui Zhang
, et al.
·
Cancer Research
·
39
RNA splicing alterations in lung cancer pathogenesis and therapy
2023
·
Yueren Yan
, Yunpeng Ren
, et al.
·
Cancer Pathogenesis and Therapy
·
16
A hybrid deep generative neural model for financial report generation
2021
·
Yunpeng Ren
, Wenxin Hu
, et al.
·
Knowledge-Based Systems
·
9
Generating Long Financial Report using Conditional Variational Autoencoders with Knowledge Distillation
2021
·
Yunpeng Ren
, Ziao Wang
, et al.
·
Proceedings of the AAAI Conference on Artificial Intelligence
·
7
PDF
Generating Financial Reports from Macro News via Multiple Edits Neural Networks
2021
·
Wenxin Hu
, Xiaofeng Zhang
, et al.
·
Lecture notes in computer science
·
6
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung Cancer
2025
·
Yueren Yan
, Ning Wang
, et al.
·
Advanced Science
·
5
Supplementary Data from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
PDF
Supplementary Table S4 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S5 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S2 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S3 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S1 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S1 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S3 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S4 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Data from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
PDF
Supplementary Table S5 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S5 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S4 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S2 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S2 from RBM10 loss promotes EGFR-driven lung cancer and confers sensitivity to spliceosome inhibition
2024
·
Yufang Bao
, Sirui Zhang
, et al.
Data from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2023
·
Yufang Bao
, Sirui Zhang
, et al.
Show more works
View as search
Works count:
35
Citation count:
136
H-index:
6
I10-index:
3
Year
Topic
Type